文献速递外周血管心血管技术与安全CTDSA

首过CT血管成像中与腹主动脉瘤3至5厘米最大径快速生长率相关的常见表现

Common First-Pass CT Angiography Findings Associated With Rapid Growth Rate in Abdominal Aorta Aneurysms Between 3 and 5 cm in Largest Diameter.
PubMed 文献 · AJR Am J Roentgenol · 2017-12-20

单中心回顾性研究纳入140例最大径3~5厘米的腹主动脉瘤患者,于2004年1月至2014年12月行CT血管成像,定量测量腔内血栓体积与管腔对比剂异质性,评估其与快速生长(>0.4厘米/年)的关系;管腔对比剂异质性、腔内血栓体积和最大径均与快速生长独立相关。

要点

  • 管腔对比剂异质性与腔内血栓体积可在腹主动脉瘤CTA上量化,二者均与快速生长独立相关。
  • 管腔对比剂异质性OR 1.16(95%CI 1.05-1.32),腔内血栓体积OR 2.15(95%CI 1.26-3.86)。
  • 最大腹主动脉瘤直径OR 1.69(95%CI 1.03-2.84),亦与快速生长独立相关。

核心结论

  • 腔内血栓与管腔对比剂异质性均可见于腹主动脉瘤CTA并可量化,二者均与快速生长率独立相关,放射科医生在监测腹主动脉瘤患者时应认识这些指标。

研究设计与样本

  • 经机构审查委员会批准并符合HIPAA的单中心回顾性研究,纳入2004年1月至2014年12月间140例腹主动脉瘤患者(男101例、女39例;平均年龄70±9岁,年龄范围22-87岁)的CTA检查。
  • 从CTA图像获取标准化的动脉瘤腔内血栓体积测量及称为「管腔对比剂异质性」的较新指标。
  • 从所有后续横断面检查获取腹主动脉瘤生长率数据,采用多变量逻辑回归评估影像表现与快速动脉瘤生长(>0.4厘米/年)的关联。
  • 将患者合并症和药物加入回归模型,评估其与快速生长率的进一步关联。

关键影像表现/征象

  • 腹主动脉瘤CTA上可见管腔对比剂异质性与腔内血栓。

诊断标准与关键数值

  • 快速动脉瘤生长定义为>0.4厘米/年。
  • 基线逻辑回归模型中,管腔对比剂异质性与快速生长几率增加独立相关(OR 1.16;95%CI 1.05-1.32)。
  • 腔内血栓体积与快速生长几率增加独立相关(OR 2.15;95%CI 1.26-3.86)。
  • 最大腹主动脉瘤直径与快速生长几率增加独立相关(OR 1.69;95%CI 1.03-2.84)。
  • 将患者合并症或药物加入基线模型后,均与结局无显著关联。

临床应用与阅片要点

  • 放射科医生在监测腹主动脉瘤患者时,应认识管腔对比剂异质性和腔内血栓这两个指标,二者可在CTA上量化并与快速生长独立相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to describe CT angiography (CTA) findings of lumen contrast heterogeneity and intraluminal thrombus volume and to evaluate their relationship with rapid aneurysm growth in patients with abdominal aortic aneurysms (AAA) between 3 and 5 cm.

MATERIALS AND METHODS: This institutional review board-approved and HIPAA-compliant single-center retrospective study included CTA studies obtained between January 2004 and December 2014 in 140 patients with AAA (101 men, 39 women; mean age ± SD, 70 ± 9 years old; age range, 22-87 years old). Standardized measurements for aneurysm intraluminal thrombus volume and a relatively new metric termed "lumen contrast heterogeneity" were obtained from the CTA images. AAA growth rate data were acquired from all subsequent cross-sectional studies. The association between the imaging findings and rapid aneurysm growth (> 0.4 cm/y) was evaluated using multivariate logistic regression. Patient comorbidities and medications were added to the regression model to assess for further associations with rapid growth rate.

RESULTS: Using a baseline logistic regression model, lumen contrast heterogeneity (odds ratio [OR], 1.16; 95% CI, 1.05-1.32), intraluminal thrombus volume (OR, 2.15; 95% CI, 1.26-3.86), and maximum AAA diameter (OR, 1.69; 95% CI, 1.03-2.84) were independently associated with increased likelihood of rapid aneurysm growth. None of the patient comorbidities or medications were significantly associated with the outcome when added to the baseline model.

CONCLUSION: Both intraluminal thrombus and lumen contrast heterogeneity are seen on AAA CTA studies and can be quantified; both of these metrics are independently associated with rapid growth rate and should be recognized by radiologists evaluating patients with AAA during surveillance.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Aghayev A, Giannopoulos AA, Gronsbell J, et al. Common First-Pass CT Angiography Findings Associated With Rapid Growth Rate in Abdominal Aorta Aneurysms Between 3 and 5 cm in Largest Diameter. AJR Am J Roentgenol. 2017. PMID: 29261347. doi:10.2214/AJR.17.18094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。